Prevention of systemic lupus erythematosus in MRL/lpr mice by administration of an immunoglobulin-binding peptide
暂无分享,去创建一个
Menotti Ruvo | G. Fassina | M. Ruvo | Maria Marino | Sandro De Falco | Giorgio Fassina | M. Marino | S. Falco
[1] G. Fassina,et al. Protein a mimetic peptide ligand for affinity purification of antibodies , 1996, Journal of molecular recognition : JMR.
[2] J. Ravetch,et al. Fc receptors initiate the Arthus reaction: redefining the inflammatory cascade. , 1994, Science.
[3] R. Jefferis,et al. Oligosaccharide‐protein interactions in IgG can modulate recognition by Fcγ receptors , 1995, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[4] M. Mattioli,et al. Heterogeneity of RNA protein antigens reactive with sera of patients with systemic lupus erythematosus. Description of a cytoplasmic nonribosomal antigen. , 1974, Arthritis and rheumatism.
[5] A. K. Singh,et al. Cytokine gene expression in the MRL/lpr model of lupus nephritis. , 1996, Kidney international.
[6] J. Kearney,et al. The Arthus Reaction in Rodents: Species-Specific Requirement of Complement1 , 2000, The Journal of Immunology.
[7] G. Steiner,et al. The lupus erythematosus cell phenomenon: comparative analysis of antichromatin antibody specificity in lupus erythematosus cell-positive and -negative sera. , 2000, Arthritis and rheumatism.
[8] M. Teitell,et al. Failed self-tolerance and autoimmunity in IgG anti-DNA transgenic mice. , 1992, Journal of immunology.
[9] D J Baylink,et al. Glucocorticoid-induced osteoporosis. , 1983, The New England journal of medicine.
[10] D. Burton,et al. Molecular recognition of antibody (IgG) by cellular Fc receptor (FcRI). , 1988, Molecular immunology.
[11] J. Banyer,et al. FcγRIIα: sequencing of the ligand binding domain in systemic lupus erythematosus patients , 1991 .
[12] G. Fassina,et al. Immunoglobulin specificity of TG19318: a novel synthetic ligand for antibody affinity purification , 1998, Journal of molecular recognition : JMR.
[13] J. Ravetch,et al. Uncoupling of immune complex formation and kidney damage in autoimmune glomerulonephritis. , 1998, Science.
[14] M. Mannik,et al. Only the initial binding of cationic immune complexes to glomerular anionic sites is mediated by charge-charge interactions. , 1986, Journal of immunology.
[15] Q. Hu,et al. Amelioration of lupus-like autoimmune disease in NZB/WF1 mice after treatment with a blocking monoclonal antibody specific for complement component C5. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[16] P. Calzavara-Pinton,et al. Chilblain lupus erythematosus is associated with antibodies to SSA/Ro , 1998, Advances in experimental medicine and biology.
[17] C. Janeway,et al. IgG anti-DNA autoantibodies within an individual autoimmune mouse are the products of clonal selection. , 1989, Journal of immunology.
[18] L. Agodoa,et al. Rearrangement of immune complexes in glomeruli leads to persistence and development of electron-dense deposits , 1983, The Journal of experimental medicine.
[19] J. Ravetch,et al. Divergent roles for Fc receptors and complement in vivo. , 1998, Annual review of immunology.
[20] W A Ray,et al. Corticosteroid use and peptic ulcer disease: role of nonsteroidal anti-inflammatory drugs. , 1991, Annals of internal medicine.
[21] T. Ternynck,et al. Two murine natural polyreactive autoantibodies are encoded by nonmutated germ-line genes. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[22] M. Mannik. Pathophysiology of circulating immune complexes. , 1982, Arthritis and rheumatism.
[23] J. Köhl,et al. A codominant role of Fc gamma RI/III and C5aR in the reverse Arthus reaction. , 2000, Journal of immunology.
[24] M. Reichlin. Current perspectives on serological reactions in SLE patients. , 1981, Clinical and experimental immunology.
[25] J. Köhl,et al. A Codominant Role of FcγRI/III and C5aR in the Reverse Arthus Reaction1 , 2000, The Journal of Immunology.
[26] N. Copeland,et al. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis , 1992, Nature.
[27] S. Ito,et al. High frequency of antibody activity against ribosomal protein S10 in anti-Sm sera from patients with systemic lupus erythematosus , 1999, Lupus.
[28] L. Kahl,et al. Risk factors for serious infection during treatment with cyclophosphamide and high-dose corticosteroids for systemic lupus erythematosus. , 1996, Arthritis and rheumatism.
[29] M. Reichlin,et al. Prevalence of autoantibodies to ribosomal P proteins in juvenile-onset systemic lupus erythematosus compared with the adult disease. , 1999, Arthritis and rheumatism.
[30] B. Kotzin. Systemic Lupus Erythematosus , 1996, Cell.
[31] D. Fearon,et al. Complement ligand-receptor interactions that mediate biological responses. , 1983, Annual review of immunology.
[32] B. Barlogie,et al. Autoregulatory circuits in myeloma. Tumor cell cytotoxicity mediated by soluble CD16. , 1995, The Journal of clinical investigation.